Cargando…

Update on optimal use of lisdexamfetamine in the treatment of ADHD

Lisdexamfetamine (LDX) has been a recent addition to the treatment armamentarium for Attention Deficit Hyperactivity Disorder (ADHD). It is unique among stimulants as it is a prodrug, and has been found to be safe and well-tolerated medication in children older than 6 years, adolescents and adults....

Descripción completa

Detalles Bibliográficos
Autores principales:	Madaan, Vishal, Kolli, Venkata, Bestha, Durga P, Shah, Manan J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3726586/ https://www.ncbi.nlm.nih.gov/pubmed/23901276 http://dx.doi.org/10.2147/NDT.S34092

Ejemplares similares

Clinical utility of the risperidone formulations in the management of schizophrenia
por: Madaan, Vishal, et al.
Publicado: (2011)

New and extended-action treatments in the management of ADHD: a critical appraisal of lisdexamfetamine in adults and children
por: Domnitei, Diana, et al.
Publicado: (2010)

By Fault or by Default
por: Madaan, Vishal, et al.
Publicado: (2012)

The Use of Lisdexamfetamine to Treat ADHD in a Patient with Stimulant (Methamphetamine) Use Disorder
por: Levine, J., et al.
Publicado: (2023)

Exploratory meta-analysis on lisdexamfetamine versus placebo in adult ADHD
por: Maneeton, Narong, et al.
Publicado: (2014)

Molecular Characterisation of the Mechanism of Action of Stimulant Drugs Lisdexamfetamine and Methylphenidate on ADHD Neurobiology: A Review
por: Quintero, Javier, et al.
Publicado: (2022)

Update on the management of attention-deficit/hyperactivity disorder in children and adults: patient considerations and the role of lisdexamfetamine
por: Cowles, Brian J
Publicado: (2009)

The Bhagavad Gita and contemporary psychotherapies
por: Bhatia, Subhash C., et al.
Publicado: (2013)

Lisdexamfetamine in the treatment of adolescents and children with attention-deficit/hyperactivity disorder
por: Najib, Jadwiga
Publicado: (2012)

Novel pharmacologic treatment in acute binge eating disorder – role of lisdexamfetamine
por: Guerdjikova, Anna I, et al.
Publicado: (2016)

Comparative efficacy, acceptability, and tolerability of lisdexamfetamine in child and adolescent ADHD: a meta-analysis of randomized, controlled trials
por: Maneeton, Benchalak, et al.
Publicado: (2015)

A Systematic Review of the Safety of Lisdexamfetamine Dimesylate
por: Coghill, David R., et al.
Publicado: (2014)

Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder
por: Najib, Jadwiga, et al.
Publicado: (2017)

Takotsubo Cardiomyopathy Due to Combined Use of Phentermine and Lisdexamfetamine
por: Burleigh, Tara, et al.
Publicado: (2020)

Lisdexamfetamine in combination with guanfacine as an effective treatment in the management of behavioral disturbances in patients with Attention Deficit Hyperactivity Disorder (ADHD) and Autism Spectrum Disorder (ASD). Case report
por: Del Sol Calderon, P., et al.
Publicado: (2023)

Lisdexamfetamine Dimesylate: Prodrug Delivery, Amphetamine Exposure and Duration of Efficacy
por: Ermer, James C., et al.
Publicado: (2016)

Impulsivity and Its Relationship With Lisdexamfetamine Dimesylate Treatment in Binge Eating Disorder
por: Griffiths, Kristi R., et al.
Publicado: (2021)

Potential for Dependence on Lisdexamfetamine - In vivo and In vitro Aspects
por: Yun, Jaesuk, et al.
Publicado: (2017)

The Cost Effectiveness of Lisdexamfetamine Dimesylate for the Treatment of Binge Eating Disorder in the USA
por: Ágh, Tamás, et al.
Publicado: (2016)

Long-Term Safety and Efficacy of Lisdexamfetamine Dimesylate in Children and Adolescents with ADHD: A Phase IV, 2-Year, Open-Label Study in Europe
por: Coghill, David R., et al.
Publicado: (2017)

Use of Lisdexamfetamine to Treat Obesity in an Adolescent with Severe Obesity and Binge Eating
por: Srivastava, Gitanjali, et al.
Publicado: (2019)

Pharmacokinetics of Coadministered Guanfacine Extended Release and Lisdexamfetamine Dimesylate
por: Roesch, Benno, et al.
Publicado: (2013)

Lisdexamfetamine: Bilateral acute angle closure: case report
Publicado: (2021)

Relative Bioavailabilities of Lisdexamfetamine Dimesylate and d-Amphetamine in Healthy Adults in an Open-Label, Randomized, Crossover Study After Mixing Lisdexamfetamine Dimesylate With Food or Drink
por: Ermer, James, et al.
Publicado: (2016)

Trial protocol of an open label pilot study of lisdexamfetamine for the treatment of acute methamphetamine withdrawal
por: Acheson, Liam S., et al.
Publicado: (2022)

Absorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamine
por: Pennick, Michael
Publicado: (2010)

Pharmacokinetics and Pharmacodynamics of Lisdexamfetamine Compared with D-Amphetamine in Healthy Subjects
por: Dolder, Patrick C., et al.
Publicado: (2017)

Lisdexamfetamine Dimesylate for Preschool Children with Attention-Deficit/Hyperactivity Disorder
por: Childress, Ann C., et al.
Publicado: (2020)

Optimal management of ADHD in older adults
por: Torgersen, Terje, et al.
Publicado: (2016)

Effect of lisdexamfetamine dimesylate on sleep in adults with attention-deficit/hyperactivity disorder
por: Adler, Lenard A, et al.
Publicado: (2009)

Rise, and pronounced regional variation, in methylphenidate, amphetamine, and lisdexamfetamine distribution in the United States
por: Vaddadi, Sneha M., et al.
Publicado: (2021)

Methylphenidate dose optimization for ADHD treatment: review of safety, efficacy, and clinical necessity
por: Huss, Michael, et al.
Publicado: (2017)

Efficacy and Safety of Lisdexamfetamine Dimesylate in Children with Attention-Deficit/Hyperactivity Disorder and Recent Methylphenidate Use
por: Jain, Rakesh, et al.
Publicado: (2013)

Patterns of Lisdexamfetamine Dimesylate Use in Children, Adolescents, and Adults with Attention-Deficit/Hyperactivity Disorder in Europe
por: Siffel, Csaba, et al.
Publicado: (2020)

Treatment outcomes after methylphenidate in adults with attention-deficit/hyperactivity disorder treated with lisdexamfetamine dimesylate or atomoxetine
por: Joseph, Alain, et al.
Publicado: (2016)

A cost-effectiveness analysis of lisdexamfetamine dimesylate in the treatment of adults with attention-deficit/hyperactivity disorder in the UK
por: Zimovetz, Evelina A., et al.
Publicado: (2017)

Update on the optimal use of bortezomib in the treatment of multiple myeloma
por: Mohan, Meera, et al.
Publicado: (2017)

Lisdexamfetamine prodrug activation by peptidase-mediated hydrolysis in the cytosol of red blood cells
por: Sharman, Johannah, et al.
Publicado: (2014)

Pharmacokinetics of Coadministered Viloxazine Extended-Release (SPN-812) and Lisdexamfetamine in Healthy Adults
por: Faison, Shamia L., et al.
Publicado: (2021)

Lisdexamfetamine to improve excessive daytime sleepiness and weight management in narcolepsy: a case series
por: Aguilar, Ana C., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_gfacqvo7lvn09fpq0g4pd3rabu